Central serous chorioretinopathy: A review.

Area of Science:

• Ophthalmology
• Retinal Diseases

Background:

• Central serous chorioretinopathy (CSC) is a significant cause of vision impairment, characterized by fluid leakage.
• Its exact pathogenesis remains unclear, but involves choroidal, scleral, and retinal pigment epithelium (RPE) changes, potentially linked to choroidal venous congestion.
• Classifications include acute, chronic, and recurrent subtypes, with recent simple and complex categories based on RPE changes.

Purpose of the Study:

• To outline the diagnosis and management of CSC.
• To discuss secondary complications like type 1 neovascularization.
• To review current treatment options for persistent or recurrent CSC.

Main Methods:

• Multimodal imaging is crucial for diagnosis and management.
• Fundus autofluorescence aids in classifying CSC subtypes.
• Indocyanine-green angiography helps identify leakage for specific treatments.

Main Results:

• Spontaneous resolution is common, often with good visual outcomes.
• Persistent or recurrent subretinal fluid (SRF) warrants treatment.
• Argon laser and photodynamic therapy show strong evidence for specific leakage types.

Conclusions:

• Multimodal imaging is essential for diagnosing and managing CSC and its complications.
• While many cases resolve spontaneously, interventions are necessary for persistent disease.
• Argon laser and photodynamic therapy are evidence-based treatments for specific CSC presentations.